Ameritas Investment Partners’s Harpoon Therapeutics, Inc. Common Stock HARP Stock Holding History

Ameritas Investment Partners’s Portfolio HARP Stock Details HARP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-110	Closed	-$5K	–	3315
2022 Q1	$5K	Hold	110	–	–	﹤0.01%	2979
2021 Q4	$8K	Hold	110	–	–	﹤0.01%	2971
2021 Q3	$9K	Hold	110	–	–	﹤0.01%	2978
2021 Q2	$15K	Hold	110	–	–	﹤0.01%	2860
2021 Q1	$23K	Buy	110 +46	+72%	+$9.22K	﹤0.01%	2518
2020 Q4	$11K	Hold	64	–	–	﹤0.01%	2762
2020 Q3	$11K	Hold	64	–	–	﹤0.01%	2689
2020 Q2	$11K	Hold	64	–	–	﹤0.01%	2692
2020 Q1	$7K	Hold	64	–	–	﹤0.01%	2718
2019 Q4	$9K	Buy	64 +43	+205%	+$6.52K	﹤0.01%	2787
2019 Q3	$3K	Hold	21	–	–	﹤0.01%	3001
2019 Q2	$3K	Hold	21	–	–	﹤0.01%	3001
2019 Q1	$2K	Buy	+21	New	+$2.76K	﹤0.01%	2956

Other funds holding HARP

MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

MAM

MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Ameritas Investment Partners's HARP Position: Q2 2022 in Review

Ameritas Investment Partners sold out of Harpoon Therapeutics, Inc. Common Stock (HARP) in Q2 2022, closing a stake of 110 shares — an estimated $5K sold.

Ameritas Investment Partners first reported a position in HARP in Q1 2019 and held it in 13 quarters. The position peaked at $23K in Q1 2021. 63 funds tracked by Wall St. Rank hold HARP as of Q2 2022.

Ameritas Investment Partners reported no remaining Harpoon Therapeutics, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
Ameritas Investment Partners sold 110 Harpoon Therapeutics, Inc. Common Stock shares in Q2 2022, an estimated $5K.
Ameritas Investment Partners first reported a position in Harpoon Therapeutics, Inc. Common Stock in Q1 2019 and held it in 13 quarters.
Ameritas Investment Partners's Harpoon Therapeutics, Inc. Common Stock position peaked at $23K in Q1 2021.
63 funds tracked by Wall St. Rank held Harpoon Therapeutics, Inc. Common Stock as of Q2 2022.

Based on Ameritas Investment Partners's 13F filing for Q2 2022, filed 12 Aug 2022.